- Consumer Products
- Latest 44.54
- Currency US$
- Change 0.56
- Percent Change 1.273 %
- Volume 3,681,855
- Thu Apr 17, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
12 months ended Dec 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Feb 12||$-0.09||May 1||$-0.17|
12 months ended Apr 18, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Incyte Corp is a drug discovery company that is using its expertise in genomics, medicinal chemistry and molecular, cellular and in vivo biology to discover and develop novel therapeutics. The company has three fully-staffed drug discovery programs underway focused primarily on the identification of new small molecule drugs for cancer and inflammation. Incyte also has strategic alliances with Lexicon Genetics and Medarex focused on the discovery and development of protein therapeutics or antibodies to treat inflammatory diseases and cancer.